课题基金 / 基金详情

ACTG 338--A PHASE II(PRAM) OF NOVEL ANTI RETROVIRAL THERAPY IN STABLE EXPERIENCE

ACTG 338--A PHASE II(PRAM) OF NOVEL ANTI RETROVIRAL THERAPY IN STABLE EXPERIENCE
ACTG 338--具有稳定经验的新型抗逆转录病毒疗法的第二阶段(PRAM)
批准号:
6303867
负责人:
Francis Gigliotti
金额:
$1.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2001-02-28

项目摘要

项目成果

Francis Gigliotti的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to 1) evaluate ZDV+3TC vs. d4T+ritonavir vs. ZDV+3TC+ritonavir with respect to the change in plasma HIV-1 RNA copy number from baseline to 48 weeks in stable HIV-infected children with greater or equal to 16 weeks of prior continuous antiretroviral therapy, and 2) evaluate the safety and tolerance of ZDV+3TC vs. d4T+ritonavir vs. ZDV+3TC ritonavir based upon laboratory and clinical toxicities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Passive and Active Immunization for Pneumocystis
  • 批准号:
    9182862
  • 项目类别:
  • 资助金额:
    $46.52万
  • 财政年份:
    2015
  • 负责人:
    Francis Gigliotti
  • 依托单位:
Monoclonal Antibodies for the Study of P. carinii
  • 批准号:
    7878315
  • 项目类别:
  • 资助金额:
    $0.66万
  • 财政年份:
    2009
  • 负责人:
    Francis Gigliotti
  • 依托单位:
P. carinii Pneumonia Lung Damage: CD8-driven Cellular and Molecular Events
  • 批准号:
    8269027
  • 项目类别:
  • 资助金额:
    $38.5万
  • 财政年份:
    2008
  • 负责人:
    Francis Gigliotti
  • 依托单位:
P. carinii Pneumonia Lung Damage: CD8-driven Cellular and Molecular Events
  • 批准号:
    8548634
  • 项目类别:
  • 资助金额:
    $11.24万
  • 财政年份:
    2008
  • 负责人:
    Francis Gigliotti
  • 依托单位:
海外基金